國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12190/12972 (94%)
Visitors : 1062001      Online Users : 1065
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Papers [0/1]
    Patents [0/20]

    Collection Statistics

    Item counts issued in 3 years:1(3.23%)
    Items With Fulltext:31(100.00%)

    Download counts of the item
    Download times greater than 0:31(100.00%)
    Download times greater than 100:31(100.00%)
    Total Bitstream Download Counts:25984(100.00%)

    Last Update: 2024-12-11 17:14


    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 1-31 of 31. (1 Page(s) Totally)
    1 
    View [10|25|50] records per page

    DateTitleRelation
    2022-08 Rosmarinic acid interferes with influenza virus A entry and replication by decreasing GSK3beta and phosphorylated AKT expression levels Journal of Microbiology, Immunology, and Infection. 2022 Aug;55(4):598-610.
    2020-12 Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors Emerging Microbes and Infections. 2020 Dec;9(1):1194-1205.
    2019-12 A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses Antiviral Research. 2019 Dec;172:Article number 104636.
    2019-04-01 A novel, potent, and orally bioavailable thiazole HCV NS5A inhibitor for the treatment of hepatitis C virus European Journal of Medicinal Chemistry. 2019 Apr 1;167:245-268.
    2018-09 Development of robust genotype 1a hepatitis C replicons harboring adaptive mutations for facilitating the antiviral drug discovery and study of virus replication Journal of Virological Methods. 2018 Sep;259:10-17.
    2017-12 Stimulatory actions of a novel thiourea derivative on large-conductance, calcium-activated potassium channels Journal of Cellular Physiology. 2017 Dec;232(12):3409-3421.
    2017-06 Mutagenesis of dengue virus protein NS2A revealed a novel domain responsible for virus-induced cytopathic effect and interactions between NS2A and NS2B transmembrane segments Journal of Virology. 2017 Jun;91(12):Article number e01836-16.
    2017-01 A potent, selective, and orally bioavailable HCV NS5A inhibitor for treatment of Hepatitis C Virus: (S)-1-((R)-2-(Cyclopropanecarboxamido)-2-phenylacetyl)-N-(4-phenylthiazo l-2-yl)pyrrolidine-2-carboxamide Journal of Medicinal Chemistry. 2017 Jan;60(1):228-247.
    2016-07 In vitro and in vivo studies of a potent capsid-binding inhibitor of enterovirus 71 Journal of Antimicrobial Chemotherapy. 2016 Jul;71(7):1922-1932.
    2014-01 A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease Antimicrobial Agents and Chemotherapy. 2014 Jan;58(1):110-119.
    2013-02 Resistance studies of a di-thiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor in replicon systems Antimicrobial Agents and Chemotherapy. 2013 Feb; 57(2):723-733.
    2012-01 Resistance analysis and characterization of a thiazole analogue, BP008, as a potent hepatitis C virus NS5A inhibitor Antimicrobial Agents and Chemotherapy. 2012 Jan;56(1):44-53.
    2011-04 Antitumor effect of BPR-DC-2, a novel synthetic cyclic cyanoguanidine derivative, involving the inhibition of MDR-1 expression and down-regulation of p-AKT and PARP-1 in lung cancer Investigational New Drugs. 2011 Apr;29(2):195-206.
    2011-04 Isatin-beta-thiosemicarbazones as potent herpes simplex virus inhibitors Bioorganic and Medicinal Chemistry Letters. 2011 Apr;21(7):1948-1952.
    2011-01 Novel dengue virus-specific NS2B/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay Antimicrobial Agents and Chemotherapy. 2011 Jan;55(1):229-238.
    2011-01 BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities Cancer Science. 2011 Jan;102(1):182-191.
    2010-10 Modulation of microglial immune responses by a novel thiourea derivative Chemico-Biological Interactions. 2010 Oct;188(1):228-236.
    2010-09-01 Synthesis, activity, and pharmacokinetic properties of a series of conformationally-restricted thiourea analogs as novel hepatitis C virus inhibitors Bioorganic and Medicinal Chemistry. 2010 Sep ;18(17):6414-6421.
    2009-11-01 Design and efficient synthesis of novel arylthiourea derivatives as potent hepatitis C virus inhibitors Bioorganic and Medicinal Chemistry Letters. 2009 Nov 1;19(21):6063-6068.
    2009-08-01 Design and synthesis of indole, 2,3-dihydro-indole, and 3,4-dihydro-2H-quinoline-1-carbothioic acid amide derivatives as novel HCV inhibitors Bioorganic and Medicinal Chemistry Letters. 2009 Aug 1;19(15):4134-4138.
    2009-07 Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71 Antimicrobial Agents and Chemotherapy. 2009 Jul;53(7):2740-2747.
    2009-04-01 Design, synthesis, and anti-HCV activity of thiourea compounds Bioorganic and Medicinal Chemistry Letters. 2009 Apr 1;19(7):1950-1955.
    2008-10-15 Analogues of 2-phenyl-ethenesulfonic acid phenyl ester have dual functions of inhibiting expression of inducible nitric oxide synthase and activating peroxisome proliferator-activated receptor gamma Bioorganic and Medicinal Chemistry Letters. 2008 Oct 15;18(20):5676-5679.
    2008-05 Antiviral activity of pyridyl imidazolidinones against enterovirus 71 variants Journal of Biomedical Science. 2008 May;15(3):291-300.
    2005-10-01 Synthesis and antipicornavirus activity of (R)- and (S)-1-[5-(4 '-chlorobiphenyl-4-yloxy)-3-methylpentyl]-3-pyridin-4-yl-imidazolidin-2-one Bioorganic and Medicinal Chemistry Letters. 2005 Oct;15(19):4206-4211.
    2005-05-19 Design, synthesis, and antipicornavirus activity of 1-[5-(4-arylphenoxy)alkyl]-3-pyridin-4-ylimidazolidin-2-one derivatives Journal of Medicinal Chemistry. 2005 May;48(10):3522-3535.
    2004-10-18 Synthesis and antienteroviral activity of a series of novel, oxime ether-containing pyridyl imidazolidinones Bioorganic and Medicinal Chemistry Letters. 2004 Oct;14(20):5051-5056.
    2004-09 Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone Antimicrobial Agents and Chemotherapy. 2004 Sep;48(9):3523-3529.
    2004-05-17 Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidinies: a novel class of potent enterovirus inhibitors Bioorganic and Medicinal Chemistry Letters. 2004 May;14(10):2519-2525.
    2004-03-08 Synthesis and in vitro cytotoxicity of 5-substituted 2-cyanoimino-4-imidazodinone and 2-cyanoimino-4-pyrimidinone derivatives Bioorganic and Medicinal Chemistry Letters. 2004 Mar;14(5):1169-1172.
    2002-04-11 Design, synthesis, and structure-activity relationship of pyridyl imidazolidinones: A novel class of potent and selective human enterovirus 71 inhibitors Journal of Medicinal Chemistry. 2002 Apr;45(8):1644-1655.

    Showing items 1-31 of 31. (1 Page(s) Totally)
    1 
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback